Medicine information
उपयोग
ST GLIPTIN GM 50+1000+1, from Steris Healthcare, is a triple-combination oral antidiabetic formulation containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. These three active ingredients work through complementary mechanisms to help manage blood glucose levels in adults with type 2 diabetes mellitus when the combination is considered appropriate by their treating physician. Composition Each tablet contains: Sitagliptin: 50 mg Metformin Hydrochloride: 1000 mg Glimepiride: 1 mg Company Name: Steris Healthcare Key Product Features Triple-combination oral antidiabetic formulation. Contains Sitagliptin, Metformin Hydrochloride, and Glimepiride. Combines complementary mechanisms of action for blood glucose management. Intended for physician-supervised type 2 diabetes management. Uses of ST GLIPTIN GM 50+1000+1 ST GLIPTIN GM 50+1000+1 may be prescribed for adults with type 2 diabetes mellitus when the treating physician determines that this combination is appropriate for their individual treatment requirements. How ST GLIPTIN GM 50+1000+1 Works Sitagliptin 50 mg: Inhibits the DPP-4 enzyme, helping support incretin activity and glucose-dependent insulin secretion. Metformin Hydrochloride 1000 mg: Helps reduce glucose production in the liver and improves the body's response to insulin. Glimepiride 1 mg: Belongs to the sulfonylurea class of antidiabetic medicines and stimulates insulin release from the pancreas. Together, these ingredients support blood glucose control through complementary mechanisms when used as prescribed. Important Safety Information ST GLIPTIN GM 50+1000+1 is a prescription medicine and should be used only under medical supervision. Glimepiride may cause hypoglycaemia (low blood sugar), particularly when meals are skipped or delayed. Metformin may cause gastrointestinal side effects and, rarely, lactic acidosis. Sitagliptin has been associated with pancreatitis and other uncommon but potentially serious adverse effects. Inform your doctor if you have kidney or liver problems, a history of pancreatitis, or take other medicines that may affect blood glucose. Appropriate kidney function assessment and regular blood glucose monitoring are important during treatment. Disclaimer: This information is for educational purposes only and does not replace professional medical advice or the approved prescribing information. About Steris Healthcare Steris Healthcare is the company associated with the ST GLIPTIN GM 50+1000+1 brand. Refer to the company's official information for verified details about its products, distribution, and business enquiries.
